Therapeutic peptides are a major class of pharmaceutical drugs owing to their target‐
binding specificity as well as their versatility in inhibiting aberrant protein‐protein …

The field of dementia research has witnessed significant developments in our understanding
of neurodegenerative disorders, with a particular focus on Alzheimer's disease (AD) and …

Nanostructure-based regulation on β-amyloid (Aβ) aggregation has shown potential in
Alzheimer's disease (AD) treatment. However, to develop an efficient therapeutic modality …

Developing diagnostics and treatments for neurodegenerative diseases (NDs) is
challenging due to multifactorial pathogenesis that progresses gradually. Advanced in vitro …

Neurodegenerative diseases are a group of diseases characterized by the progressive loss
of neurons, including Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral …

The authors' previous research has shown the pivotal roles of Cyclin-dependent kinase 5
(CDK5) and its regulatory protein p35 in nerve growth factor (NGF)-induced differentiation of …

The cyclin-dependent kinases 12 (CDK12) and 13 (CDK13) govern several steps of gene
expression, including transcription, RNA processing and translation. The main target of …

Central nervous system disorders are prevalent, profoundly debilitating, and poorly
managed. Developing innovative treatments for these conditions, including Alzheimer's …

The nervous system plays a leading role in the regulation of physiological functions and
activities in the body. However, a variety of diseases related to the nervous system have a …

Preventing β-amyloid (Aβ) peptide aggregation by Au nanoparticles (NPs) is a promising
strategy for the treatment of Alzheimer's disease. However, construction of Au …